Jim Cramer’s High Dividend Stock Picks

Former hedge fund manager Jim Cramer now takes his skills to the masses as a CNBC host and television personality whose stock picks have tended to outperform the S&P 500. Because of his background and popularity he can be a good investor to follow and certainly a source of potential investment ideas that can be researched in depth. We have looked through the stocks that Cramer’s charitable trust reported owning recently and looked up each position to find the three stocks in the portfolio with the highest dividend yield. All three of these stocks yield over 4% given the current dividend and stock price, making them- at least for now- on par with or even superior to a number of fixed-income opportunities. However, when interest rates eventually rise, investors who are currently in these stocks on an income basis may shift to other asset classes. This makes it important to learn more about the companies behind the dividend yield to try to make sure that the high yield has not artificially inflated the stock price too far above fundamental value.

Jim Cramer

The highest dividend yield of the stocks owned by Cramer’s trust belonged to Energy Transfer Partners LP (NYSE:ETP), at 8.2%. Energy Transfer Partners primarily gathers, processes, and transports natural gas through a network of pipelines and facilities, with one segment of its business providing transportation and processing services for natural gas liquids. Its market capitalization of about $11 billion is not only about 12 times the annualized dividend payout but also about 9 times trailing earnings. The company therefore also has value characteristics as well as returning a generous portion of its earnings to shareholders fairly quickly. The past few quarters worth of results have been volatile, and the stock is about flat over the last year compared to an S&P index that has risen 21%; even given the dividend yield, the market has left Energy Transfer Partners in the dust.

Vale SA (NYSE:VALE) was another high-yield pick in the trust’s portfolio, carrying a dividend yield of 7.1%. The Brazilian company focuses on the production of iron ore and other metals and also has fertilizer and transportation businesses. It therefore carries exposure to the Brazilian economy as well as the rest of Latin America. Vale’s stock price has fallen 37% over the last year, which has helped push the dividend yield up and also has helped generate low trailing and forward earnings multiples of 6 and 5, respectively. For purposes of comparison, Australian BHP Billiton Limited (NYSE:BHP) trades at 12 times trailing earnings and 11 times 2013 estimates, and pays a dividend yield of 3.6%. It in turn is tied to another large developing economy- China. However, both of these mining companies saw sharply negative growth last quarter compared to a year ago: revenue decreased, and earnings fell by at least 40%. Cliff Asness’s AQR Capital Management was an owner of Vale at the end of June, while Vinik Asset Management reported an investment in BHP Billiton (see more stock picks from Cliff Asness and Jeffrey Vinik).

Cramer’s trust also owns shares of Bristol Myers Squibb Co. (NYSE:BMY), whose dividend yield is 4.1%. The $56 billion market cap biopharmaceutical company has a broad portfolio of pharmaceutical products and is a defensive stock with a beta of only 0.2. Bristol Myers Squibb is another company which didn’t do well last quarter, as its revenue fell 18% and its earnings fell 29% compared to the same period in the previous year. Sell-side analysts expect more trouble next year, and the stock trades at 18 times forward earnings compared to a trailing P/E of 16. AstraZeneca plc (NYSE:AZN), which pays a slightly lower yield at 3.9%, is a good peer for Bristol Myers Squibb. AstraZeneca also saw its business decline in its most recent quarter but is lower priced at a trailing P/E of only 7, and might make for a better value play at a fairly close dividend yield.

Out of these three picks from Cramer, we think that Energy Transfer Partners and Vale are priced low enough compared to the core business that the high dividend yields are still worth chasing. We’re not as sure about Bristol-Myers Squibb, as at least one comparable company offers a similar yield at a lower multiple of its earnings; however, because of the nature of the drug development business, it is possible that the company’s pipeline is strong enough to justify this disparity.

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

The 10 Worst Mistakes an Entrepreneur Can Make

The 5 Most OP Characters in League of Legends to Carry Games and Crush Foes With

The 5 Best Foods to Eat Before Running that Will Help You Pound the Pavement

10 Glaring Plot Holes in The Walking Dead that a Zombie-Filled Bus Could Drive Through

The 5 Biggest Celebrity Stoners Who Love Their Reefer

The 10 Most Overrated Movies Of All Time by Out-of-Touch Critics

Top 6 Least Expensive Cruise Destinations For 2015 that Will Take You to Paradise

10 States with Lowest Substance Abuse Rates in America

The 14 Most Watched TV Finales Ever

The 10 Best Selling Role Playing Games of All Time for PC

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

How to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

5 Pitfalls To Avoid When Buying a Franchise

Top 20 Medical Schools in the US – 2014 Rankings

4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef

6 Qualities That Make You A Good Team Player

10 High Paying Seasonal Jobs in America this Holiday Season

The 10 Busiest Shipping Lanes in the World

5 Most Valuable Brands in China

The 10 States with Highest Substance Abuse Rates Crippling Their Populace

The Top 10 Things to Do Before You Die That Will Echo for Eternity

The 10 Best Selling Items on Etsy

Top 10 Things to Do in Tokyo, the Greatest City in the World

10 Mistakes on Social Media that Can Harm You and Will Probably Get You Canned

The 10 Best Cities to Find Jobs in 2014

The 10 Most Controversial Songs Of All Time to Hit (and get Banned from) the Airwaves

The 20 Biggest IPOs in US History

The 10 Best Places to Visit in Mexico that Are Beautiful and Safe

7 Bad Habits that Age You Beyond Your Years

The 40 Best Fortune Cookie Sayings That Will Leave You Bemused, Befuddled, or Beguiled

10 Foods to Eat Before a Workout to Make Every Drop of Sweat Count

The 5 Best Documentaries On Netflix You Must See

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!